Episode Details
Back to Episodes
Personalized mRNA Vaccine Shows Promise Against Melanoma | Health and Fitness News
Description
Moderna and Merck just dropped a game-changing update on a personalized melanoma vaccine using mRNA tech—same as in COVID shots. In a late-stage trial, the vaccine paired with Keytruda kept high-risk patients’ cancer from returning or spreading after surgery. Scientists are tailoring it to each patient’s tumor genetics, essentially giving the immune system a custom “wanted poster” for cancer cells. Experts are calling it a true breakthrough, marking a major leap forward in precision medicine. No new safety issues emerged, and researchers are now exploring its potential for other cancers like lung, kidney, and bladder. FDA approval could come as early as next year—this is one to watch.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/fae5c3d58cb828f2